Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05NYR
|
||||
Former ID |
DNC013149
|
||||
Drug Name |
H-Dmt-Tic-(2R,3R)-beta-MeCha-Phe-OH
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Discovery agent | Investigative | [528621] | ||
Structure |
Download2D MOL |
||||
Formula |
C40H50N4O6
|
||||
Canonical SMILES |
CC1=CC(=CC(=C1CC(C(=O)N2CC3=CC=CC=C3CC2C(=O)NC(C(C)C4CC<br />CCC4)C(=O)NC(CC5=CC=CC=C5)C(=O)O)N)C)O
|
||||
InChI |
1S/C40H50N4O6/c1-24-18-31(45)19-25(2)32(24)22-33(41)39(48)44-23-30-17-11-10-16-29(30)21-35(44)37(46)43-36(26(3)28-14-8-5-9-15-28)38(47)42-34(40(49)50)20-27-12-6-4-7-13-27/h4,6-7,10-13,16-19,26,28,33-36,45H,5,8-9,14-15,20-23,41H2,1-3H3,(H,42,47)(H,43,46)(H,49,50)/t26-,33+,34+,35?,36-/m1/s1
|
||||
InChIKey |
GWHRSTGESQKJIQ-RUXLTPPNSA-N
|
||||
PubChem Compound ID | |||||
Target and Pathway | |||||
Target(s) | Mu-type opioid receptor | Target Info | Inhibitor | [528621] | |
Delta-type opioid receptor | Target Info | Inhibitor | [528621] | ||
NetPath Pathway | TCR Signaling Pathway | ||||
PANTHER Pathway | Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | ||||
Heterotrimeric G-protein signaling pathway-Gq alpha and Go alpha mediated pathway | |||||
Enkephalin releaseP00026:Heterotrimeric G-protein signaling pathway-Gi alpha and Gs alpha mediated pathway | |||||
Enkephalin release | |||||
Opioid proenkephalin pathway | |||||
Opioid proopiomelanocortin pathway | |||||
Pathway Interaction Database | IL4-mediated signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.